Back to dashboard
All PlansCoverageMedium impact

New policy

Blue Cross Blue Shield of Rhode Island·RI · Urology·Provider Update
Effective date
Mar 1, 2023
We identified it
Jun 19, 2026
Days to comply

Summary

BCBS Rhode Island has created a new policy for Temporarily Implanted Nitinol Device (iTind) for Benign Prostatic Hyperplasia. This establishes coverage guidelines for a specific urological device/procedure that was previously not covered under a formal policy.

Action Required

Action needed
Immediately: Billing team should review the full iTind policy text in the Provider section of bcbsri.com under Medical Policy heading to understand coverage criteria, prior authorization requirements, and billing guidelines for this urological procedure. Notify urology providers of the new coverage policy.